124 related articles for article (PubMed ID: 8217343)
1. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin.
Masood R; Husain SR; Rahman A; Gill P
AIDS Res Hum Retroviruses; 1993 Aug; 9(8):741-6. PubMed ID: 8217343
[TBL] [Abstract][Full Text] [Related]
2. Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy.
Gordon KB; Tajuddin A; Guitart J; Kuzel TM; Eramo LR; VonRoenn J
Cancer; 1995 Apr; 75(8):2169-73. PubMed ID: 7697608
[TBL] [Abstract][Full Text] [Related]
3. KS: a new drug and, maybe, a new bug.
Gilden D
GMHC Treat Issues; 1995 Jan; 9(1):11-12. PubMed ID: 11367378
[TBL] [Abstract][Full Text] [Related]
4. Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells.
Mallery SR; Pei P; Kang J; Ness GM; Ortiz R; Touhalisky JE; Schwendeman SP
Anticancer Res; 2000; 20(5A):2817-25. PubMed ID: 11062689
[TBL] [Abstract][Full Text] [Related]
5. Doxil offers hope to KS sufferers.
Prescott LM
J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43-4. PubMed ID: 11363097
[TBL] [Abstract][Full Text] [Related]
6. DOXIL superior for KS.
Posit Aware; 1995; ():7. PubMed ID: 11362576
[TBL] [Abstract][Full Text] [Related]
7. KS update.
Notes Undergr; 1995; (no 29):4. PubMed ID: 11362282
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
Goebel FD; Goldstein D; Goos M; Jablonowski H; Stewart JS
Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
[TBL] [Abstract][Full Text] [Related]
9. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
[TBL] [Abstract][Full Text] [Related]
10. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
Harrison M; Tomlinson D; Stewart S
J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
Coukell AJ; Spencer CM
Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
[TBL] [Abstract][Full Text] [Related]
13. Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: clinical, histological and cell biological evaluation.
Stürzl M; Zietz C; Eisenburg B; Goebel FD; Gillitzer R; Hofschneider PH; Bogner JR
Res Virol; 1994; 145(3-4):261-9. PubMed ID: 7800953
[TBL] [Abstract][Full Text] [Related]
14. New treatment for KS offers options for therapy.
AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.
Northfelt DW; Martin FJ; Working P; Volberding PA; Russell J; Newman M; Amantea MA; Kaplan LD
J Clin Pharmacol; 1996 Jan; 36(1):55-63. PubMed ID: 8932544
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma: DOX-SL approval recommended.
AIDS Treat News; 1995 Feb; (no 217):8. PubMed ID: 11362308
[TBL] [Abstract][Full Text] [Related]
17. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
Hengge UR; Brockmeyer NH; Baumann M; Reimann G; Goos M
Lancet; 1993 Aug; 342(8869):497. PubMed ID: 8102452
[No Abstract] [Full Text] [Related]
18. Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin.
Hengge UR; Esser S; Rudel HP; Goos M
Eur J Cancer; 2001 May; 37(7):878-83. PubMed ID: 11313176
[TBL] [Abstract][Full Text] [Related]
19. KS treatment inches forward.
Vazquez E
Posit Aware; 1996; 7(5):9. PubMed ID: 11363790
[TBL] [Abstract][Full Text] [Related]
20. DOXIL approved for KS.
James JS
AIDS Treat News; 1995 Dec; (no 236):6. PubMed ID: 11363051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
